According to the Low Dose Naltrexone home page [LDN], LDN has been seen to benefit
Pemphigoid Disorders, which are considered to be an autoimmune disease.
[LDN_Autoimmune] presents a case report of Dr. Bernard Bihari treating one patient
having Pemphigoid with LDN, obtaining gradual remission of symptoms over 6 weeks.
[Albers2017 🕮 ] reports a case series of 3 patients diagnosed with severe Hailey-Hailey disease who were
treated with LDN. All patients "noted significant healing of erosions and plaques ... within 1 to 2 weeks of treatment,
and clinical resolution of lesions within 2 months."
[Ibrahim2017 🕮 ] reports a case series of 3 patients who exhibited at least an 80% reduction in extent of
Hailey-Hailey disease after treatment with low-dose naltrexone.
[Cao2018 🕮 ] reports a case series of 3 patients treated with up to 12.5mg naltrexone/day; 2 out of 3
of the patients had a good respose. One patient had complete resolution of symptoms in 2 months, while a second patient
had 95% resolution of symptoms after 18 months.
[Riquelme-McLoughlin2019 🕮 ] reports a case series of 14 patients, in which 2 patients had a sustained response of
> 1 year, 6 patients had an initial improvement but relapsed, 4 patients discontinued the treatment because of
ineffectiveness, and 2 patients discontinued the treatment because of adverse events [yes, I know this adds up to more
than 14, but that is what was reported]..
Starting doses varied from 1.5 to 6mg/day.
Increasing the dose of naltrexone to 25 or 50mg/day did not improve results.
[McBride2020 🕮 ] [McBride2019] reports a case of a 50-year-old woman with a 20-year history of
Hailey-Hailey disease, who showed significant clinical improvement after 26 days of treatment with LDN 1.5mg HS.
[Alajmi2019] reports a case of a 54-year-old man with a 30-year history of Hailey-Hailey disease,
was treated with 4.5mg/day along with magnesium chloride, which yielded a dramatic improvement over the 2 weeks with
excellent pain control.
[Sonthalia2019 🕮 ] reports a case of a 42-year-old male with treatment-refractory Hailey-Hailey disease
who remitted with 5mg/day LDN, but relapsed on stopping the drug. Symptoms abated after restarting LDN.
The mechanism of action of LDN in treating Hailey-Hailey disease appears to be via Toll-like receptor 4
antagonism and/or opioid growth factor antagonism [Toljan2018 🕮 ].
Dr. Weyrich has been trained in the use of Low Dose Naltrexone (LDN).
However, Dr. Weyrich has not treated any cases of Pemphigoid Disorder
with LDN.
Please see What is Low Dose Naltrexone?
for more information.
[McCulley2018, pg 61] reports that pemphigus is an
autoimmune disorder, and proposes an approach to treating this disease, which should be
supervised by a properly trained medical professional.
Dr. Weyrich has considerable interest in this topic, but has
not treated any cases of pemphigus
with Immune System Balancing.
Please see What is Immune System Balancing?
for more information.
Neuro Research [Hinz2015] reports that
chronic diseases such as pemphigus
can be benefited by balancing neurotransmitter levels in the body.
Dr. Weyrich has been trained in neurotransmitter balancing protocols, but has not treated
pemphigus using this technique.
Please see What is Neurotransmitter Balancing?
for more information.